Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Stephanie Okey

Director at Ptc Therapeutics, Inc. (PTCT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M

Reported trades

Filed Stock Type Shares Price Value Since
Mar 12SEC PTCTPtc Therapeutics, Inc. Sell Plan 1,1678,000 held (−13%) $70.00 $82K -15.4%
Mar 12SEC PTCTPtc Therapeutics, Inc. Sell Plan 14,0008,000 held (−64%) $70.00 $980K -15.4%
Mar 9SEC PTCTPtc Therapeutics, Inc. Sell Plan 6,3338,000 held (−44%) $63.38 $401K -6.5%
  • Sell

    Director Stephanie Okey sold $82K of PTCT at $70.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Stephanie Okey sold $980K of PTCT at $70.00 — cuts the stake by 64%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Stephanie Okey sold $401K of PTCT at $63.38 — cuts the stake by 44%; pre-scheduled 10b5-1 plan sale.